Antiviral medications are recommended for use in patients with mild-to-moderate COVID-19 within 5 days of symptom onset for those who are at risk of progression to severe disease due to age or other underlying conditions.
However, a recent study found that __ of the recommended patient population were not offered antiviral medications.